Sarmazenil

Sarmazenil
Clinical data
AHFS/Drugs.com	International Drug Names
ATCvet code	QV03AB91 (WHO) ;
Identifiers
	IUPAC name Ethyl 7-chloro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate;
CAS Number	78771-13-8 ;
PubChem CID	71231;
ChemSpider	64366 ;
UNII	F84AE7X24P;
ChEMBL	ChEMBL46547 ;
CompTox Dashboard (EPA)	DTXSID70229281 ;
Chemical and physical data
Formula	C15H14ClN3O3
Molar mass	319.75 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC=C3Cl)C;
	InChI InChI=1S/C15H14ClN3O3/c1-3-22-15(21)13-11-7-18(2)14(20)12-9(16)5-4-6-10(12)19(11)8-17-13/h4-6,8H,3,7H2,1-2H3 ; Key:WSDBAFQWNWJTNG-UHFFFAOYSA-N ;
	(what is this?) (verify)

Sarmazenil (Ro15-3505) is a drug from the benzodiazepine family. It acts as a partial inverse agonist of benzodiazepine receptors,^[1] meaning that it causes the opposite effects to most benzodiazepine drugs, and instead acts as an anxiogenic and convulsant. It is used in veterinary medicine to reverse the effects of benzodiazepine sedative drugs in order to rapidly re-awaken anesthetized animals.^[2]^[3]^[4]